Browse All

Current Filters

CLEAR FILTER x

TITLE

RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP

Author:Cashman, Neil   Zhao, Beibei   Cowan, Catherine   Saraph, Ananya   Christy, Darren   Coutts, Juliane   Kaplan, Johanne   

Session Name:P1: Aging and Dementia: Basic Science  

Topic:Aging and Dementia  

Program Number:P1.003  

Author Institution:ProMIS Neurosciences, Vancouver, BC, Canada  University of British Columbia, Vancouver, BC, Canada  ProMIS Neurosciences, Sherborn, MA  

Life’s Simple 7 and the Risk of Dementia among Women

Author:Rist, Pamela   Power, Melinda   Lee, I-Min   Buring, Julie   

Session Name:P2: Neuroepidemiology 2  

Topic:Neuroepidemiology  

Program Number:P2.030  

Author Institution:Brigham and Women's Hospital, Boston, MA  George Washington University, Washington DC, DC  

Real-World Evaluation of Serum Sodium Levels in Patients With Focal Seizures Treated With Eslicarbazepine Acetate

Author:Mitchell, Guy   Cantu, David   Mehta, Darshan   Grinnell, Todd   Smith, David   

Session Name:P4: Epilepsy/Clinical Neurophysiology (EEG): Real-World Use of ASMs  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P4.010  

Author Institution:Sumitovant Biopharma, Inc., New York, NY  Sunovion Pharmaceuticals Inc. , Fort Lee, NJ  Sunovion Pharmaceuticals Inc. , Marlborough, MA  

Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis

Author:Benedict, Ralph   Penner, Iris Katharina   Cutter, Gary   Kappos, Ludwig   Coyle, Patricia   Piani-Meier, Daniela   Azmon, Amin   Boer, Ibolya   Su, Wendy   Cohen, Jeffrey   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.005  

Author Institution:Department of Neurology, University At Buffalo, Buffalo, NY  Medical Faculty, Department of Neurology, Heinrich Heine University, COGITO Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany  UAB School of Public Health, Birmingham, AL  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland  Department of Neurology, SUNY At Stony Brook, Stony Brook, NY  Novartis Pharma AG, Basel, Switzerland  Novartis Pharmaceuticals Corporation, East Hanover, NJ  Department of Neurology, Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH  

Optimizing Management and Outcomes of Large Vessel Occlusion Ischemic Stroke Utilizing Mobile Stroke Units

Author:Tariq, Muhammad Bilal   Parker, Stephanie   Jacob, Asha   Wang, Mengxi   Singh, Noopur   Yamal, Jose-Miguel   Phan, Kenny   Bratina, Patti   Bowry, Ritvij   Grotta, James   Czap, Alexandra   

Session Name:P8: Cerebrovascular Disease and Interventional Neurology: Interventional Neurology  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P8.002  

Author Institution:University of Texas Health Science Center at Houston, Houston, TX  Memorial Hermann Hospital-TMC, Houston, TX